Serum angiotensin converting enzyme and C4 protein of complement as a combined diagnostic index in alcoholic liver disease

Liver

Volumn 16, Issue 5, 1996, Pages 303-308

  Sopeña, Barnardo ^a   Martínez Vázquez, César ^a   Fernández Rodríguez, Conrado M ^a   De La Fuente, Javier ^a   Rivera, Alberto ^a   Rodríguez, Miguel ^b   Gómez, Mary Carmen ^a   Prieto, Jesús ^c  

^a HOSPITAL XERAL CÍES   (Spain)

^b Hospital de Verin   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Alcoholism; Diagnostic index; SACE; SACE C4 ratio

Indexed keywords

COMPLEMENT COMPONENT C4; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME BLOOD LEVEL; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE;

EID: 0029909151     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1996.tb00750.x     Document Type: Article

References (43)

1. SCHEIG R. That demon rum. Am J Gastroenterol 1991: 86: 150-152.
2. RANKIN J G D, ORREGO H, DESCHENES J, MEDLINE A, FINDLAY J E, ARMSTRONG A I M. Alcoholic liver disease: the problem of diagnosis. Alcohol Clin Exp Res 1978: 2: 3270328.
3. LEVIN D M, BAKER A L, RIDDELL R H, et al. Nonalcoholic liver disease: overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med 1979: 66: 429-434.
4. WHITING-O'KEEFE Q E, FYE K, SACK JK. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am J Med 1991: 90: 711-716.
5. MAHARAJ B, MAHARAJ R J, LEARY W P, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986: 1: 523-525.
6. PACCININO F, SAGNELLI E, PASQUALE G, GIUSTI G. Complications following percutaneous liver biopsy: a multicenter retrospective study on 68,276 biopsies. J Hepatol 1986: 2: 165-173.
7. JANES C, LINDOR K D. Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med 1993: 118: 96-98.
8. POYNARD T, AUBERT A, BEDOSSA P, et al. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology 1991: 100: 1397-1402.
9. JOHNSON D A, DIEHL A M, SJÖGREN M H, LAZAR J, CATTAU E L, SMALLRIDGE R C. Serum angiotensin converting enzyme activity in evaluation of patients with liver disease. Am J Med 1987: 83: 256-260.
10. SOPEÑA B, MARTÍNEZ-VÁZQUEZ C, JIMÉNEZ-BEATTY M, RODRÍGUEZ M, PRIETO I. Utilidad de la enzima convertidora de la angiotensina sérica, en la diferenciación de ictericias intra y extrahepáticas. Rev Clin Esp 1991: 188: 267-268.
11. SCHWEISFURTH H, WERNZE H. Changes of serum angiotesin I-converting enzyme in patients with viral hepatitis and liver cirrhosis. Acta Hepato-Gastroenterol 1979: 26: 207-210.
12. THOMPSON R A, CARTER R, STOKES R P, GEDDES A M, GOODALL J A D. Serum immunoglobulins, complement component levels and autoantibodies in liver diseases. Clin Exp Immunol 1973: 14: 335-346.
13. MUÑOZ L E, VILLIERS D, MARKHAM D, WHALEY K, THOMAS H C. Complement activation in chronic liver disease. Clin Exp Immunol 1982: 47: 548-554.
14. BLAKE J, ORREGO H. Monitoring treatment of alcoholic liver disease: evaluation of various severity indices. Clin Chem 1991: 37: 5-13.
15. MADDREY W C. Alcoholic hepatitis: clinicopathologic features and therapy Semin Liv Dis 1988: 8: 91-102.
16. HARJANNE A. Automated kinetic determination of angiotensin converting enzyme in serum. Clin Chem 1984: 30: 901-903.
17. Diagnostic test. In: Altman D, ed. Practical statistics for medical research. London: Chapman & Hall. 1991: 408-419.
18. SHERLOCK S. Alcohol and the liver. In: Sherlock S, ed. Diseases of the liver and bilinary system, 8th edn. Oxford: Blackwell Scientific Publications. 1990: 425-448.
19. GRANT B F, DUFOUR M C, HARFORD T C. Epidemiology of alcoholic liver disease. Semin Liv Dis 1988: 8: 12-25.
20. LIEBER C S, SALASPURO M. Alcoholic liver disease. In: Wright R, Millward-Sadler G H, Alberti K G M, Karran S, eds. Liver and biliary disease, 2nd edn. London: Bailliere-Tindall, 1985: 882-947.
21. SAUNDERS J B, DAVIS M, WILLIAMS R. Do women develop alcoholic liver disease more readily than men? Br Med J 1981: 282: 1140-1143.
22. ERDÖS E G, SKIDGEL R A. The angiotensin I-converting enzyme. Lab Invest 1987: 56: 345-348.
23. BALLERMAN B J, ZIEDEL S, GUNNING A J, BRENNER B M. Vasoactive peptides and the kidney. In: Brenner B M, Rector F C, eds. The kidney. 4th edn. Philadelphia: W. B. Saunders Company. 1991: 517-519.
24. SCHARPE S, NEELS H, VAN SANDE H. Biochemical and clinical aspects of angiotensin converting enzyme. Topics in Biochemistry 1989: 25-32.
25. GOTO M, FUJISAWA M, YAMADA A, et al. Spontaneous release of angiotensin-converting enzyme and interleukin-1β from peripheral blood monocytes from patients with rheumatoid arthritis under a serum-free condition. Ann Rheum Dis 1990: 49: 172-176.
26. OKABE T, YAMAGATA K, FUJISAWA M, WATNANABE J, TAKAKU F. Increased angiotensin-converting enzyme in peripheral blood monocytes from patients with sarcoidosis. J Clin Invest 1985: 75: 911-914.
27. STUDDY P, BIRD R, JAMES D G, SHERLOCK S. Serum angiotensin-converting enzyme (SACE) in sarcoidosis and other granulomatous disorders. Lancet 1978: 2: 1331-1334.
28. SCHULTZ T, MILLER W C, BEDROSSIAN C W M. Clinical application of measurement of angiotensin-converting enzyme level. JAMA 1978: 242: 439-441.
29. LIEBERMAN J, BEUTLER E. Elevation of SACE in Gaucher's disease. N Engl J Med 1976. 294: 1442-1444.
30. LIEBERMAN J. A new confirmatory test for sarcoidosis. Serum angiotensin converting enzyme: effect of steroids and chronic lung disease. Am Rev Res Dis 1974: 109: 743.
31. BOROWSKY S A, LIEBERMAN J, STROME S, SASTRE A. Elevation of serum angiotensin-converting enzyme. Occurrence in alcoholic liver disease. Arch Intern Med 1982: 142: 893-895.
32. MATSUKI K, SAKATA T. Angiotensin-converting enzyme in diseases of the liver. Am J Med 1982: 73: 549-551.
33. MESTRE M, BAS J, BUENDÍA E, MAÑÁ J, BADRINAS F. Enzima de conversión de la angiotensina y otras alteraciones bioquímicas. In: Badrinas F, Moreira Prats J, eds. Sarcoidosis. 1st edn. Barcelona: Doyma, 1989: 297-312.
34. SMALLRIDGE R C. Angiotensin-converting-enzyme activity in acute illness. Semin Resp Med 1985: 7: 34-38.
35. DEVIERE J, CONTENT J, DENYS C, et al. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokine production. Clin Exp Immunol 1989: 77: 221-225.
36. IWAMOTO H, SAKAMOTO S, NAWATA H. Serum factor from patients with cirrhosis and hepatocellular carcinoma enhances production of prostaglandin E2 by U937 cells. Hepatology 1991: 14: 1123-1128.
37. ROCCO V K. Cirrhotic ascites. Pathophysiology, diagnosis and management. Ann Intern Med 1986: 105: 573-585.
38. MUÑOZ L E, VELLIERS D, MARKHAM D, WHALEY K, THOMAS H C. Complement activation in chronic liver disease. Clin Exp Immunol 1982: 47: 548-554.
39. MACGREGOR R R. Alcoholic and immune defense. JAMA 1986: 256: 1474-1479.
40. THOMPSON R A, CARTER R, STOKES R P, GEDDES A M, GOODALL J A D. Serum immunoglobulins, complement component levels and autoantibodies in liver diseases. Clin Exp Immunol 1973: 14: 335-346.
41. PETZ L D. Variable mechanisms for low serum-complement in liver disease. Lancet 1971: 2: 1033-1034.
42. FOX R A, DUDLEY F J, SHERLOCK S. The serum concentration of the third component of complement β1C-β1A in liver disease. Gut 1971: 12: 574-579.
43. TEISBERG P, GJONE E. Circulating conversion products of C3 in liver disease: evidence for in vitro activation of the complement system. Clin Exp Immunol 1973: 14: 509-514.